查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970989

絲胺酸蛋白酶市場 - 全球產業規模、佔有率、趨勢、機會、預測（按類型、應用、地區和競爭對手分類），2021-2031年

Serine Proteases Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segment By Type (C1r, C1s, C3a, and C3b), By Application (Digestive System, Blood Coagulation System, Complement System, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球絲胺酸蛋白酶市場預計將從 2025 年的 27.5 億美元成長到 2031 年的 37.4 億美元，複合年成長率為 5.26%。

這個市場涵蓋了一大類酶，這些酶的活性位點含有親核絲胺酸殘基，能夠催化蛋白質中肽鍵的水解。市場成長的主要促進因素是其在製藥領域治療血液凝固障礙的應用不斷擴展，以及在清潔劑工業領域的應用日益廣泛，並有助於提高食品加工效率。例如，根據世界血友病聯盟於2024年發布的《2023年全球調查報告》，全球用於治療B型血友病的必需絲胺酸蛋白酶－凝血因子IX濃縮物的消費總量已達到1,716,125,572國際單位，這充分說明了該治療領域的規模。

市場概覽
預測期 2027-2031
市場規模：2025年 27.5億美元
市場規模：2031年 37.4億美元
複合年成長率：2026-2031年 5.26%
成長最快的細分市場 補體系統
最大的市場 亞太地區

另一方面，阻礙市場擴張的主要障礙在於重組絲胺酸蛋白酶的開發和純化高成本且技術複雜。生產商必須遵守嚴格的監管條件，並採用昂貴的生物製程技術以確保安全性和有效性，這往往會延遲產品上市，並限制其在成本敏感發展中地區的供應。這些挑戰構成了巨大的准入壁壘，限制了產品的獲取，導致儘管臨床和工業需求明確，低收入地區的市場仍無法充分發揮其潛力。

市場促進因素

藥物發現和開發的快速發展是絲胺酸蛋白酶市場的主要驅動力。這些酵素既是重要的治療靶點，也是不可或缺的生物製程工具。製藥公司正大幅增加對新型生物製藥和蛋白酶抑制劑研發的投入，從而催生了對用於胜肽合成和蛋白質序列測定的高純度酵素的需求。研發活動的激增導致對用於檢測方法開發和生產流程的專用絲胺酸蛋白酶的採購量增加。例如，默克在2024年2月發布的2023年度報告中揭露，其研發投入高達305億美元，凸顯了巨額資本投入對生化試劑和藥物發現工具的需求。

同時，慢性病和酵素相關疾病的日益增多推動了市場發展，催生了對先進診斷和治療解決方案的需求。絲胺酸蛋白酶對於診斷癌症和凝血障礙等疾病至關重要，它們既可作為生物標記物，也可作為溶栓療法的活性成分。隨著這些疾病在全球範圍內的負擔日益加重，基於蛋白酶的診斷和治療方法需求也顯著成長。美國癌症協會在2024年1月發布的《2024年癌症事實與數據》報告中預測，僅在美國就將新增2,001,140例癌症病例，凸顯了需要酵素管理的患者群體不斷擴大。此外，諾維信公司公佈2023年全年總收入達179億丹麥克朗，反映出這項專業生物化學市場的整體穩定性。

市場挑戰

重組絲胺酸蛋白酶的開發和純化成本高且技術複雜，是全球絲胺酸蛋白酶市場擴張的主要障礙。生產商必須滿足嚴格的生物加工要求，以確保這些酶（尤其是治療性酶，例如凝血因子IX）安全有效且不含病毒污染。這些嚴格的生產標準需要大量的資本投入和先進的技術基礎設施，直接推高了產品的最終價格。因此，這些重要的酵素在發展中國家的醫療系統和患者中仍然難以負擔，而市場的潛在消費群也主要局限於高所得國家。

這些經濟壁壘的影響在全球產品使用方面的顯著差異中得到了清晰體現。根據世界血友病聯盟於2024年發布的《2023年全球調查報告》，全球人均凝血因子IX使用量僅0.22國際單位（IU）。這一極低的中位數表明，儘管治療藥物已存在，但由於生產過程複雜導致高成本，阻礙了絕大多數國家廣泛採用這些藥物。因此，在人口眾多但對成本敏感的新興經濟體中，對這些治療方法的需求很高，但購買力有限，限制了市場充分發揮其成長潛力。

市場趨勢

在絲胺酸蛋白酶市場，採用耐冷酵素開發永續清潔劑配方正迅速改變產業格局。製造商正擴大低溫下高效蛋白酶的使用，以滿足消費者對節能洗衣解決方案的需求，並遵守嚴格的環境法規。這一趨勢促使高性能絲胺酸蛋白酶被應用於高階液體清潔劑中，有效取代了需要熱水水解蛋白質污漬的傳統界面活性劑。這些先進配方的商業性成功已在關鍵產業公司的財務表現中充分體現。例如，聯合利華在2024年2月發布的「2023年全年業績報告」中指出，其家居護理業務部門實現了5.9%的銷售額成長，這主要歸功於紡織清潔領域基於科學的創新成果的成功應用。

在製藥領域，整合人工智慧和結構生物學的合理抑制劑設計正在改變絲胺酸蛋白酶標靶療法的研發。計算平台如今能夠以前所未有的精度預測複雜酶-抑制劑的結合親和性，使研究人員能夠標靶化參與凝血和免疫通路的特定蛋白酶亞型，同時避免脫靶效應。這種技術融合顯著縮短了蛋白酶調節劑的先導藥物最適化和臨床試驗過渡所需的時間，領先的製藥公司正在大力投資人工智慧主導的藥物研發夥伴關係。根據禮來公司和Isomorphic Labs於2024年1月發布的關於策略合作的新聞稿，兩家公司已達成總額高達17億美元的協議，旨在利用先進的人工智慧技術來識別針對複雜生物標的的小分子療法。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球絲胺酸蛋白酶市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（C1r、C1s、C3a、C3b）
    • 依應用（消化器官系統、血液凝固系統、補體系統等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美絲胺酸蛋白酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲絲胺酸蛋白酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區絲胺酸蛋白酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲絲胺酸蛋白酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美絲胺酸蛋白酶市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球絲胺酸蛋白酶市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Novozymes A/S
  • Biocatalysts Ltd.
  • BASF SE
  • DuPont de Nemours Inc
  • Amano Enzyme Inc
  • DSM BV
  • Antozyme Biotech Pvt. Ltd
  • Bioseutica BV

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20070

The Global Serine Proteases Market is projected to expand from USD 2.75 Billion in 2025 to USD 3.74 Billion by 2031, reflecting a compound annual growth rate of 5.26%. This market encompasses a broad family of enzymes defined by a nucleophilic serine residue at their active site, which catalyzes the hydrolysis of peptide bonds within proteins. Market growth is largely driven by the increasing application of these enzymes in the pharmaceutical sector for treating blood coagulation disorders, alongside their industrial utility in improving the efficiency of laundry detergents and food processing. Highlighting the scale of the therapeutic segment, the World Federation of Hemophilia reported in its 2023 Annual Global Survey, released in 2024, that the total global consumption of Factor IX concentrates-a critical serine protease for hemophilia B treatment-reached 1,716,125,572 International Units.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.75 Billion
Market Size 2031USD 3.74 Billion
CAGR 2026-20315.26%
Fastest Growing SegmentComplement System
Largest MarketAsia Pacific

Conversely, a major obstacle hindering broader market expansion is the high cost and technical complexity involved in developing and purifying recombinant serine proteases. Manufacturers are required to navigate strict regulatory landscapes and employ expensive bioprocessing technologies to guarantee safety and efficacy, which often delays product launches and restricts availability in cost-sensitive developing regions. These challenges create significant barriers to entry and limit accessibility, preventing the market from reaching its full potential in lower-income areas despite the evident clinical and industrial demand.

Market Driver

The rapid acceleration of pharmaceutical drug discovery and development serves as a primary catalyst for the serine proteases market, as these enzymes function as both critical therapeutic targets and essential bioprocessing tools. Pharmaceutical companies are significantly increasing their investment in research and development to engineer novel biologics and protease inhibitors, creating a need for high-purity enzymes for peptide synthesis and protein sequencing. This surge in R&D activity leads to increased procurement of specialized serine proteases for assay development and production workflows. For instance, Merck & Co., Inc. reported in its '2023 Annual Report' in February 2024 that it invested $30.5 billion in research and development, underscoring the massive capital allocation that drives the demand for biochemical reagents and discovery tools.

Simultaneously, the growing prevalence of chronic diseases and enzyme-related disorders propels market momentum by necessitating advanced diagnostic and therapeutic solutions. Serine proteases are integral to diagnosing conditions such as cancer and coagulation disorders, serving as biomarkers, and acting as active pharmaceutical ingredients in thrombolytic therapies. As the global burden of these pathologies rises, the requirement for protease-based diagnostics and treatments escalates significantly. The American Cancer Society projected in 'Cancer Facts & Figures 2024' (January 2024) that 2,001,140 new cancer cases will occur in the United States alone, highlighting the expanding patient pool requiring enzymatic management. Furthermore, Novozymes reported a total revenue of DKK 17.9 billion for the full year 2023, reflecting the broader stability supporting these specialized biochemical markets.

Market Challenge

The substantial cost and technical complexity associated with the development and purification of recombinant serine proteases constitute a major hurdle hampering the broader expansion of the Global Serine Proteases Market. Manufacturers face rigorous bioprocessing requirements to ensure that these enzymes-particularly therapeutic ones like Factor IX-are safe, effective, and free from viral contaminants. These stringent production standards necessitate significant capital investment and advanced technical infrastructure, which directly inflates the final price of the products. Consequently, these essential enzymes remain financially inaccessible to healthcare systems and patients in developing regions, restricting the market's addressable consumer base primarily to high-income nations.

The impact of this affordability barrier is evident in the stark disparity in product usage rates globally. According to the World Federation of Hemophilia's Report on the Annual Global Survey 2023, published in 2024, the median global per capita usage of Factor IX was only 0.22 International Units. This extremely low median figure indicates that, despite the availability of these treatments, the high costs driven by manufacturing complexities prevent widespread adoption in the majority of countries. As a result, the market struggles to realize its full growth potential in populous but cost-sensitive emerging economies, where the demand for such therapies is high but purchasing power is limited.

Market Trends

The adoption of cold-adaptive enzymes for sustainable detergent formulations is rapidly altering the industrial landscape of the serine proteases market. Manufacturers are increasingly utilizing engineered proteases that function optimally at low temperatures to meet consumer demand for energy-efficient laundry solutions and comply with strict environmental regulations. This trend drives the inclusion of high-performance serine proteases in premium liquid detergents, effectively replacing traditional surfactants that require hot water to hydrolyze protein-based stains. The commercial success of these advanced formulations is evident in the financial performance of major sector players; for example, Unilever reported in its 'Full Year 2023 Results' in February 2024 that its Home Care business group achieved an underlying sales growth of 5.9 percent, attributed to the successful scaling of science-backed innovations in fabric cleaning.

In the pharmaceutical sector, the integration of artificial intelligence and structural biology for rational inhibitor design represents a transformative shift in therapeutic development involving serine proteases. Computational platforms are now capable of predicting complex enzyme-inhibitor binding affinities with unprecedented accuracy, allowing researchers to target specific protease subtypes involved in clotting and immune pathways without off-target effects. This technological convergence significantly reduces the time required for lead optimization and clinical entry for protease-modulating drugs, prompting major pharmaceutical companies to invest heavily in AI-driven discovery partnerships. According to Eli Lilly and Company's January 2024 press release regarding a strategic collaboration with Isomorphic Labs, the firm committed to a total deal value of up to $1.7 billion to utilize advanced AI technologies for identifying small molecule therapies against challenging biological targets.

Key Market Players

  • Novozymes A/S
  • Biocatalysts Ltd.
  • BASF SE
  • DuPont de Nemours Inc
  • Amano Enzyme Inc
  • DSM BV
  • Antozyme Biotech Pvt. Ltd
  • Bioseutica BV

Report Scope

In this report, the Global Serine Proteases Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Serine Proteases Market, By Type

  • C1r
  • C1s
  • C3a
  • C3b

Serine Proteases Market, By Application

  • Digestive System
  • Blood Coagulation System
  • Complement System
  • Others

Serine Proteases Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Serine Proteases Market.

Available Customizations:

Global Serine Proteases Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Serine Proteases Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (C1r, C1s, C3a, C3b)
    • 5.2.2. By Application (Digestive System, Blood Coagulation System, Complement System, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Serine Proteases Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Serine Proteases Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Serine Proteases Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Serine Proteases Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Serine Proteases Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Serine Proteases Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Serine Proteases Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Serine Proteases Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Serine Proteases Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Serine Proteases Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Serine Proteases Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Serine Proteases Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Serine Proteases Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Serine Proteases Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Serine Proteases Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Serine Proteases Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Serine Proteases Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Serine Proteases Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Serine Proteases Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Serine Proteases Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Serine Proteases Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Serine Proteases Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Serine Proteases Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Serine Proteases Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Serine Proteases Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Novozymes A/S
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Biocatalysts Ltd.
  • 15.3. BASF SE
  • 15.4. DuPont de Nemours Inc
  • 15.5. Amano Enzyme Inc
  • 15.6. DSM BV
  • 15.7. Antozyme Biotech Pvt. Ltd
  • 15.8. Bioseutica BV

16. Strategic Recommendations

17. About Us & Disclaimer